Sova Health, India’s pioneering full-stack gut health company, has broadened its personalised digestive care services by introducing two advanced diagnostic tools — the Gut Microbiome Test (GMT) and the Food Intolerance Test (FIT). These new offerings aim to provide science-backed, personalised interventions for digestive health.

Leveraging a proprietary gut microbiome database with over 35,000 samples from whole genome sequencing, Sova Health focuses on decoding gut bacteria, short-chain fatty acids (SCFAs), and key metabolic indicators. This approach allows the company to move beyond generic treatments, identifying root causes related to metabolism, immunity, and mental well-being.

Co-founder and Chief Scientific Officer Max Kushnir highlighted the company’s mission to merge cutting-edge gut health science with everyday wellness through genomic insights. These diagnostics empower individuals with tailored, accurate data to better manage their digestive health.

Integrated into a larger ecosystem of personalised diet plans and custom probiotics like SovaX — Asia’s first made-to-order probiotic — these tests reflect Sova Health’s commitment to precise, evidence-based care. All patient data is handled securely, complying with Indian Council of Medical Research (ICMR) standards, and users retain the right to request data deletion.

With users already reporting reduced symptoms and improved gut health, Sova Health aims to further expand its offerings with upcoming diagnostics for skin, oral microbiome, and full-body metabolic analysis, advancing its vision of personalised wellness through microbiome science.